Logo Helmholtz Munich
Scientific & Professional Training -

Scientific & Professional Training

Our Mission - Creating a unique structured translational training and education platform to ultimately raise future (clinician-)scientist leaders in respiratory medicine and science.

Read more...

News & Events

04.11.2022

Congratulations, Michal!

Michal Mastalerz (Staab-Weijnitz Lab) has successfully defended his thesis entitled "Validation and application of human in vitro models for...

11.10.2022

Strong impression: Young investigators from the DZL Munich site awarded prizes at the (DZL) DPLD Young Investigator Meeting

At the end of September, young investigators from all sites of the German Center of Lung Research (DZL) in the field of DPLD (Diffuse Parenchymal Lung...

11.10.2022

EPAA Travel Grant for Ashesh Chakraborty

Ashesh Chakraborty, a Ph.D. student at Staab-Weijnitz lab “Immune barriers in lung health and disease” has been awarded a student travel grant of 1000...

22.06.2022

Congratulations Vijay!

Vijayanand Rajendran, member of the CPC Research School, successfully defended his Ph.D. thesis: "Harnessing Adeno Associated Virus (AAV) Technology...

23.03.2022

Master Thesis Research Project: In vitro mini-lung model

Are you interested in miniaturized in vitro models such as lung-on-chip?

We, the Laboratory for Pulmonary Aerosol Delivery (AG Dr. Schmid) at the...

Quick Facts

The MD/PhD Program at the Comprehensive Pneumology Center (CPC) aims to create a unique translational training and education platform to ultimately raise future (clinician-)scientist leaders in respiratory medicine and science.

The program benefits from its supporting partners - the Helmholtz Zentrum München - German Research Center for Environmental Health - and the Ludwig-Maximilians-University and the university hospital system - thereby providing an excellent and inspiring environment for translational research.

Moreover, the Spokesperson and Program Coordinator are supported by an advisory board that includes representatives of all main stakeholders from the Institute of Lung Biology and Disease, Research Unit Lung Repair and Regeneration, and Institute of Epidemiology at Helmholtz Munich.

(Clinician-)Scientists trained within the program have diverse career options in the expanding biomedical field, and will undoubtedly be able to advance our understanding of lung disease and develop novel therapies for improving the care and quality of life of patients suffering from lung disease.

November - 2022
Mo Tu We Th Fr Sa Su
31 01 02 03 04 05 06
07 08 09 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
28 29 30 01 02 03 04